Product Finder

Select by:

View all products
View all news

Other Products from this Line


Packages containing l5 and 30 coated tablets.

View more


Dispense in container of 30 and 60 film-coated tablets.

View more

Pelmec AT 5/50 - Pelmec AT 5/100

Containers with 30 double-layered tablets. 

View more


Containers with 28 tablets. 

View more

Product Line:

Cardiometabolism Line

Patient Product Information

Rosuvastatin Calcium 5,20 mg; Excipients  q.s; Rosuvastatin Calcium 10,40 mg; Excipients  q.s

Therapeutic action.

Cholesterol lowering treatment - HMG-CoA reductase inhibitor.


Adjuvant to the diet to reduce the levels of C-total, C-LDL, ApoB, C-noHDL and TG, and increase C-HDL. Pharmacological action: selective and competitive inhibitor of HMG-CoA reductase. 

Dosage and route of administration.

Administer as a single dose at any time of the day, with or without food. The dose range is 5 to 40 mg. Recommended initial dose: 10 mg/day.


Known hypersensitivity to any component of the product; active liver disease or unaccountable persistent elevations in serum transaminases; pregnancy and breastfeeding. 

Warnings and Precautions.

Liver enzymes: it is advised to measure them before and 12 weeks after the initiation of therapy and in case of any increase in dose. Use with caution in patients who consume substantial quantities of alcohol and/or have a history of liver disease. Advise patients to report immediately any unexplained pain, tenderness o muscle weakness. 

Adverse reactions.

Generally, they are mild and transient. The most frequent ones are myalgia, constipation, asthenia, abdominal pain and nausea. 


Container with 28 coated tablets.